|
Sign In to gain access to subscriptions and/or personal tools.
|
Enhanced regional AT2-receptor and PKC expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction
Bodh I Jugdutt
Cardiology Division, Department of Medicine, University of Alberta, Edmonton, Alberta, bjugdutt{at}ualberta.ca
Mohammed Balghith
Cardiology Division, Department of Medicine, University of Alberta, Edmonton, Alberta
We assessed the effects of the angiotensin II (Ang II) type 1 receptor (AT1-receptor) blocker, candesartan, (CN, 1 mg/kg i.v. over 30 minutes pre-ischaemia) alone or after intracoronary administration of Ang II type 2 receptor (AT 2-receptor) blocker (PD 123319), protein kinase C (PKC) inhibitor (chelerythrine), endothelial nitric oxide (NO) synthase inhibitor (NG-monomethyl-L-arginine or L-NMMA), and bradykinin (BK) -B2 receptor inhibitor (HOE140) on in vivo left ventricular (LV) function and remodelling (echocardiograms/ Doppler) and haemodynamics in 30 dogs with reperfused anterior infarction (90 minutes ischaemia, 120 minutes reperfusion), and ex vivo infarct size, AT1-receptor/AT2-receptor proteins and PKC (immunoblots), and cyclic guanosine 3', 5' monophosphate (cGMP, immunoassay). Compared with controls, CN inhibited the Ang II pressor response, reduced LV preload, improved LV systolic and diastolic function, limited LV remodelling, decreased infarct size, and increased AT2-receptor and PKC proteins in the infarct zone (IZ), and these responses were abrogated by PD 123319, chelerythrine, L-NMMA and HOE140. In addition, the increase in LV cGMP with CN was attenuated by PD 123319, L-NMMA and HOE140. The overall results suggest that AT2-receptor activation and signalling via BK, PKC and cGMP contribute to cardioprotection associated with AT1-receptor blockade during ischaemia-reperfusion injury.
Key Words: AT1-receptor AT2-receptor PKC cGMP ischaemia-reperfusion
References
- Yoshiyama M., Kim S., Yamagishi H. et al. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury. Am Heart J 1994;128:1-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Werrmann JG, Cohen SM Use of losartan to examine the role of the cardiac renin-angiotensin system in myocardial dysfunction during ischemia and reperfusion. J Cardiovasc Pharmacol 1996;27:177-82.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yang BC, Phillips MI,Ambuehl PEJ, Shen LP, Mehta P., Mehta JL Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat heart. Circulation 1997;96:922-6.[Abstract/Free Full Text]
- JalowyA, Schulz R., Dorge H., Behrends M., Heush G. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2 receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 1998;32:1787-96.[Abstract/Free Full Text]
- Jugdutt BI, Xu Y., Balghith M., Moudgil R., Menon V. Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: Association with regional increase in AT2R, IP3R and PKC
proteins and cGMP. J Cardiovasc Pharmacol Thera 2000;5:301-11.[CrossRef] - Xu Y., Menon V., Jugdutt BI Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-e in acutely reperfused myocardial infarction. Effect of UP269-6 and losartan on AT1 and AT2 receptor expression, and IP3 receptor and PKC
proteins. JRAAS 2000;1:184-95. - Ford WR, Khan MI, Jugdutt BI Effect of the novel angiotensin II type 1 receptor antagonist L-158,809 on acute infarct expansion and acute anterior myocardial infarction in the dog. Can J Cardiol 1998;14:73-80.[Web of Science][Medline]
[Order article via Infotrieve]
- Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997;99:1926-35.[Web of Science][Medline]
[Order article via Infotrieve]
- Wiemer G., Schölkens BA, Wagner A., Heitsch H., Linz W. The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens 1993;11:S234-S235.[Web of Science]
- Jugdutt, BI, Xu Y., Balghith M., Menon V. Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: Role of angiotensin II type 2 receptor. JRAAS 2001;2:S162-S166.
- Ping P., Takano H., Zhang J. et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits. A signaling mechanism for both nitric-oxide-induced and ischemia-induced preconditioning. Circ Res 1999;84:587-604.[Abstract/Free Full Text]
- Yasmin W., Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 1997;33:422-32.[Abstract/Free Full Text]
- Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate. Circulation 1995;92:926-34.[Abstract/Free Full Text]
- Jugdutt BI Effect of reperfusion on ventricular mass, topography and function during healing of anterior infarction. Am J Physiol 1997;272:H1205-11.[Web of Science][Medline]
[Order article via Infotrieve]
- Douglas PS, Tallant B. Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension. J Am Coll Cardiol 1991;17:530-6.[Abstract]
- Becker LC, Jeremy RW, Schaper J., Schaper W. Ultrastructural assessment of myocardial necrosis occurring during ischemia and 3-h reperfusion in the dog. Am J Physiol 1999;277: H243-H252.[Web of Science][Medline]
[Order article via Infotrieve]
- Jugdutt BI, Becker LC, Hutchins GM Early changes in collateral blood flow during myocardial infarction in conscious dogs. Am J Physiol 1979;237:H371-H380.[Web of Science][Medline]
[Order article via Infotrieve]
- Dörge H., Behrends M., Schulz R., Jalowy A., Heusch G. Attenuation of myocardial stunning by the AT1 receptor antagonist candesartan. Basic Res Cardiol 1999;94:208-14.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Siragy HM, Inagami T., Ichiki T., Carey RM Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA 1999;96:6506-10.[Abstract/Free Full Text]
- Gohlke P., Pees C., Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998;31:349-55.[Abstract/Free Full Text]
- Seyedi N., Xu XB, Nasjletti A., Hintze TH Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995;26:164-70.[Abstract/Free Full Text]
- Jugdutt BI Angiotensin II receptor blockers. In Crawford MH (ed): Cardiology Clinics Annual of Drug Therapy (vol 2). Saunders, Philadelphia, PA, pp. 1-17, 1998.
- Yamada T., Horiuchi M., Dzau VJ Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996;93:156-60.[Abstract/Free Full Text]
- Tanaka M., Tsuchida S., Imai T. et al. Vascular response to angiotensin II is exaggerated through an upregulation of AT1 Receptor in AT2 knockout mice. Biochem Biophys Res Comm 1999;258:194-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Masaki H., KuriharaT.,YamakiA. et al. Cardiac-specific over-expression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest 1998;101:527-35.[Web of Science][Medline]
[Order article via Infotrieve]
- Youhua Z., Shouchun X. Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system. Chin Med J 1995;108:28-32.[Web of Science][Medline]
[Order article via Infotrieve]
- Ichiki T., Usui M., Kato M., Funakoshi Y., Ito K., Egashira K., Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998;31:342-8.[Abstract/Free Full Text]
- Laursen JB, Rajagopalan S., Galis Z.,Tarpey M., Freeman BA, Harrisin DG Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95:588-93.[Abstract/Free Full Text]
- Brew EC, Mitchell MB, RehringTF et al. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol 1995;269:H1370-H1378.[Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 2,
134-140 (2001)
DOI: 10.3317/jraas.2001.015

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Kumar, V. Menon, W. R. Ford, A. S. Clanachan, and B. I. Jugdutt
Effect of Angiotensin II lype 2 Receptor Blockade on Activation of Mitogen-Activated Protein Kinases after Ischemia-Reperfusion in Isolated Working Rat Hearts
Journal of Cardiovascular Pharmacology and Therapeutics,
December 1, 2003;
8(4):
285 - 296.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. I. Jugdutt and V. Menon
Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat
Journal of Cardiovascular Pharmacology and Therapeutics,
September 1, 2003;
8(3):
217 - 226.
[Abstract]
[PDF]
|
 |
|
|
|